VANCOUVER, BC / ACCESSWIRE / December 10, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the “Company“) is pleased to announce a non-brokered private placement (the “Offering“) financing of up to 4,167,000 units (the “Units“) of the Company at a price of $0.12 per Unit for gross proceeds of $500,040. Each Unit consists of one common share and one-half of one common share purchase warrant, with each whole warrant entitling the holder to acquire an additional common share of the Company at a price of $0.20 for a period of twelve (12) months from the closing of the Offering. The Company may pay a finder’s fee to one or more arm’s length parties who introduce the Company to subscribers, in accordance with the policies of the Canadian Securities Exchange.
The funds will be used for the development of the business, potential acquisitions and working capital purposes. Shares issued pursuant to the Offering are subject to a four-month and one day hold period from the closing date in accordance with applicable securities laws.
FOR MORE INFORMATION PLEASE CONTACT:
EGF THERAMED HEALTH CORP.
Doug McFaul
Email: dmcfaul@emprisecapital.com
Telephone: (778) 331-8505
Disclaimer and Forward-Looking Statements
This news release may include forward-looking statements that are subject to inherent risks and uncertainties. All statements within this news release, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those described in forward-looking statements. Factors that could cause actual results to differ materially from those described in forward-looking statements include fluctuations in market prices, including metal prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under applicable laws.
SOURCE: EGF Theramed Health Corp
View source version on accesswire.com:
https://www.accesswire.com/620497/EGF-Theramed-Health-Corp-Announces-500040-Non-Brokered-Private-Placement
LONDON, UNITED KINGDOM / ACCESSWIRE / July 10, 2024 / TR-1: Standard form for notification…
Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases HAMBURG,…
GOTHENBURG, SWEDEN / ACCESSWIRE / July 10, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…
WESTLAKE, Texas, July 9, 2024 /PRNewswire/ -- AvodahMed is pleased to announce the appointment of…
ALLENTOWN, Pa., July 9, 2024 /PRNewswire/ -- HNL Lab Medicine is excited to announce the…
Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…